Outcomes in TN Breast Cancer Predicted by Blood Biomarkers Outcomes in TN Breast Cancer Predicted by Blood Biomarkers

Biomarkers of residual disease at surgery identify which triple-negative breast cancer patients already treated with neoadjuvant therapy will do well and which will do poorly over the next 2 years.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news